WeVote

Bill

Bill

H 2214

An Act relative to substance use disorder evaluations

194th Legislature (2025-2026) Introduced by Kim Ferguson and 4 co-sponsors

The bill requires the Department of Public Health to annually collect and report locations, frequency, and post-evaluation opioid overdose treatment outcomes.

Accompanied a study order, see H5319 (under House Rule 27)
0
WeVote Research Nonpartisan
Bill Summary · H 2214

Summary: H.2214 – An Act relative to substance use disorder evaluations

Overview

H.2214, introduced February 27, 2025, seeks to enhance oversight of substance use disorder evaluations by adding an annual data collection and reporting requirement for the Department of Public Health (DPH). The bill amends Chapter 111, section 51 ½, to create a new subsection (i) focused on tracking evaluation frequency, location, and post-evaluation outcomes related to opioid overdoses. A hearing is scheduled for November 10, 2025 (1:00 PM–5:00 PM, in hearing room A-2).

Key Provisions

  • Amends Section 51 ½ of Chapter 111 by inserting new subsection (i).
  • Data collection obligation: DPH shall annually collect, in a manner determined by the department, the frequency and location of substance abuse evaluations ordered under this section.
  • Outcome reporting: The annual report must include the number of individuals who received a substance abuse evaluation and returned to an acute care facility within the same calendar year for treatment related to an opioid overdose. -Reporting recipients: The department must submit the data to the Joint Committee on Health Care Financing, the Joint Committee on Mental Health and Substance Use, and the House and Senate Committees on Ways and Means.
  • Timing: The annual report is due not later than January 1 of each year.

Purpose and Impact

  • Purpose: To improve transparency and data-driven understanding of how substance use disorder evaluations are utilized and how often patients return to acute care for opioid-related treatment after an evaluation.
  • Impact: Facilities conducting evaluations and public health planners would be subject to new data collection and mandatory reporting. Legislators and committees would gain annual statistics on evaluation frequency, locations, and linkage to subsequent overdose-related treatment.

Affected Parties

  • Department of Public Health (DPH) responsible for data collection and reporting.
  • Health care facilities and providers conducting substance use disorder evaluations.
  • State legislators and legislative committees (Health Care Financing; Mental Health and Substance Use; Ways and Means) receiving annual reports.
  • Individuals undergoing substance use disorder evaluations and, if applicable, those who experience opioid overdoses requiring acute care after evaluation.

Procedural and Timeline Details

  • Legislative action: Referred to the Mental Health, Substances Use and Recovery committee on 2/27/2025; Senate concurrence noted; hearing scheduled for 11/10/2025 (A-2).
  • Related bill context: Similar matter previously filed as House Bill 1991 in the 2023-2024 session; “HD 2240 (replaces)” indicates House docket 2240 is the current or replacement measure.
  • Data reporting schedule: Annual, with the first report due by January 1 following enactment (exact effective date not specified in the text provided).

Notes

  • The bill text specifies the collection method is to be determined by the department, indicating implementation details would be refined post-enactment.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.